#immunic
Latest news and interesting information about immunic.
H.C. Wainwright Reiterates Immunic Stock Rating
H.C. Wainwright maintains Buy rating and $22 price target on Immunic stock. The company awaits pivotal MS drug trial results. Read more on Bond.az.
...
